Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 16, 2021 22:21 UTC |
Tachibana AaronChief Financial Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070025 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,094 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs shall vest in semi-annual installments over three years with the first installment of 13,333 RSUs vesting on June 14, 2022. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 22:14 UTC |
Chen RichardChief Medical Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070009 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,073 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs shall vest in semi-annual installments over three years with the first installment of 13,333 RSUs vesting on June 14, 2022. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 23:05 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 4,184 | $12.92 | $54,057.28 |
DisclosureSEC source: 0001209191-21-068172 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,094 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 23:06 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 419 | $12.92 | $5,413.48 |
DisclosureSEC source: 0001209191-21-068173 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,073 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 17:49 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 100,000 | $13.65 | $1,365,000.00 |
DisclosureSEC source: 0001209191-21-067691 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,444 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $13.65, and the range of prices were between $13.36 and $14.17. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 18:15 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 2,348 | $17.04 | $40,009.92 |
DisclosureSEC source: 0001209191-21-065918 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,444 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 23:14 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 1,253 | $17.04 | $21,351.12 |
DisclosureSEC source: 0001209191-21-065917 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,278 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 23:12 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,253 | $17.04 | $21,351.12 |
DisclosureSEC source: 0001209191-21-065916 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,781 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:12 UTC |
Chen RichardChief Medical Officer
|
GrantCommon Stock | 711 | $16.68 | $11,859.48 |
DisclosureSEC source: 0001209191-21-065916 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,492 F2 · shares: These Shares are being voluntarily reported on this Form 4 to report the acquisition by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 18:24 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 100,000 | $19.33 | $1,933,000.00 |
DisclosureSEC source: 0001209191-21-060503 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,792 F1 · price: The weighted average sale price for the transaction reported was $19.33, and the range of prices were between $19.06 and $19.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 22:36 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,152 | $21.25 | $66,980.00 |
DisclosureSEC source: 0001209191-21-057101 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,531 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 22:35 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,088 | $21.25 | $23,120.00 |
DisclosureSEC source: 0001209191-21-057100 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,034 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 18:28 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 6,600 | $22.28 | $147,048.00 |
DisclosureSEC source: 0001209191-21-056465 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,792 F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $22.28, and the range of prices were between $22.19 and $22.45. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 18:28 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 93,400 | $21.65 | $2,022,110.00 |
DisclosureSEC source: 0001209191-21-056465 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,392 F1 · price: The weighted average sale price for the transaction reported was $21.65, and the range of prices were between $21.17 and $22.15. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:51 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,820 | $21.92 | $83,734.40 |
DisclosureSEC source: 0001209191-21-055047 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,683 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:50 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 291 | $21.92 | $6,378.72 |
DisclosureSEC source: 0001209191-21-055046 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,122 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 17:52 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 77,272 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-053893 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 77,272 shares Expires 2022-03-07 F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. F2 · derivative.underlying_shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 17:52 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 77,272 | $0.44 | $33,999.68 |
DisclosureSEC source: 0001209191-21-053893 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787,792 Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 18:14 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 115,228 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-052991 · doc4.xml · derivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,271 Underlying: Common Stock · 115,228 shares Expires 2022-03-07 F3 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. F2 · derivative.underlying_shares: The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 18:14 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerCommon Stock | 115,228 | $16.81 | $1,936,982.68 |
DisclosureSEC source: 0001209191-21-052991 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710,520 F1 · price: The weighted average sale price for the transaction reported was $16.81, and the range of prices were between $16.60 and $17.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. F2 · price: The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 18:14 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 115,228 | $0.44 | $50,700.32 |
DisclosureSEC source: 0001209191-21-052991 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825,748 Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,946 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,946 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,618 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · derivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,728 Underlying: Common Stock · 9,618 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 4,436 | $21.22 | $94,131.92 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,413 F1 · shares: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $21.22, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 15,564 | $21.18 | $329,645.52 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $21.18, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:04 UTC |
Tachibana AaronChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001179110-21-007743 · edgar.xml · derivative · entry 2 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2031-07-27 F2 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest monthly over four (4) from the Vesting Commencement Date, subject to the reporting person's Continuous Service. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:04 UTC |
Tachibana AaronChief Financial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007743 · edgar.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,503 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The shares shall vest in a series of eight (8) semi-annual installments measured from the Vesting Commencement Date, such that the award will be fully vested after four (4) years, subject to the reporting person's Continuous Service. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:06 UTC |
Chen RichardChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001179110-21-007744 · edgar.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2031-07-27 F2 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest monthly over four (4) from the Vesting Commencement Date, subject to the reporting person's Continuous Service. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:06 UTC |
Chen RichardChief Scientific Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007744 · edgar.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,980 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The shares shall vest in a series of eight (8) semi-annual installments measured from the Vesting Commencement Date, such that the award will be fully vested after four (4) years, subject to the reporting person's Continuous Service. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 18:34 UTC |
West John StephenDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-047487 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,499 Underlying: Common Stock · 75,000 shares Expires 2022-03-07 F1 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. F2 · derivative.underlying_shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 18:34 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 75,000 | $0.44 | $33,000.00 |
DisclosureSEC source: 0001209191-21-047487 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710,520 Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 17:07 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-046303 · doc4.xml · derivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,499 Underlying: Common Stock · 110,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. F3 · derivative.underlying_shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 17:07 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 110,000 | $22.54 | $2,479,400.00 |
DisclosureSEC source: 0001209191-21-046303 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,520 F1 · price: The weighted average sale price for the transaction reported was $22.54, and the range of prices were between $21.37 and 22.85. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 17:07 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 110,000 | $0.44 | $48,400.00 |
DisclosureSEC source: 0001209191-21-046303 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,520 Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:10 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 2,421 | $22.75 | $55,077.75 |
DisclosureSEC source: 0001209191-21-042442 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,503 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:09 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,101 | $22.75 | $25,047.75 |
DisclosureSEC source: 0001209191-21-042441 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,980 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 17:15 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-041531 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,499 Underlying: Common Stock · 75,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. F2 · derivative.underlying_shares: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 17:15 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 75,000 | $0.44 | $33,000.00 |
DisclosureSEC source: 0001209191-21-041531 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,520 Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:17 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-039558 · doc4.xml · derivative · entry 4 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,499 Underlying: Common Stock · 110,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:17 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 9,950 | $22.93 | $228,153.50 |
DisclosureSEC source: 0001209191-21-039558 · doc4.xml · nonDerivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,520 F2 · price: The weighted average sale price for the transaction reported was $22.93, and the range of prices were between $22.88 and $23.00. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:17 UTC |
West John StephenDirector · President and CEO
|
SaleCommon Stock | 100,050 | $22.38 | $2,239,119.00 |
DisclosureSEC source: 0001209191-21-039558 · doc4.xml · nonDerivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,470 F1 · price: The weighted average sale price for the transaction reported was $22.38, and the range of prices were between $21.76 and $22.75. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:17 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 110,000 | $0.44 | $48,400.00 |
DisclosureSEC source: 0001209191-21-039558 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670,520 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 22:48 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 2,899 | $21.57 | $62,531.43 |
DisclosureSEC source: 0001209191-21-038402 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,924 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 22:46 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 291 | $21.57 | $6,276.87 |
DisclosureSEC source: 0001209191-21-038399 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,081 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 16:16 UTC |
West John StephenDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 107,500 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001209191-21-033473 · doc4.xml · derivative · entry 3 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,500 Underlying: Common Stock · 107,500 shares Expires 2031-05-15 F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments with the first installment vesting on June 15, 2021. Read SEC document |
| May 15, 2021 Filed May 18, 2021 16:16 UTC |
West John StephenDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001209191-21-033473 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2031-05-15 F3 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments with the first installment vesting on April 17, 2023. Read SEC document |
| May 15, 2021 Filed May 18, 2021 16:16 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 53,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033473 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,520 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 8 equal semi-annual installments with the first installment vesting on November 15, 2021. F2 · balance_after: Includes 2,300 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on April 30, 2020 and corrects for 942 shares that were incorrectly previously reported as acquired under the ESPP. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:18 UTC |
Tachibana AaronChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001209191-21-033475 · doc4.xml · derivative · entry 2 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-15 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments with the first installment vesting on June 15, 2021. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:18 UTC |
Tachibana AaronChief Financial Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033475 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,823 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 8 equal semi-annual installments with the first installment vesting on November 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.